some cancer cells can evade immune destruction by acquiring the ability to inhibit immune checkpoint regulatory pathways and suppress anti-cancer immune responses. In recent years, the immune checkpoints took ... stage…
regulation of anti-tumor responses by immune-checkpoint blockade is a new approach for the treatment of advanced solid malignant tumors. There are some demerits to this therapy that require ... eligibility and efficacy…
Immune checkpoint blockade plays a crucial role in mounting antitumor immunity thereby improving cancer survival. Immune checkpoint inhibitors (ICIs) targeting programmed cell death protein 1 (PD-1) and cytotoxic…
relapsed cases. Recent insights into tumor immunology have led to the exploration of immune checkpoint inhibitors and biomarker-driven strategies to personalize treatment. This article examines the role of immune…
Checkpoint inhibitors have revolutionized oncology by harnessing the immune system to recognize and attack cancer cells. Agents targeting CTLA-4, PD-1, and PD-L1 have shown unprecedented success ... cost-related…
Immune checkpoint inhibitors (ICIs) targeting PD-1 (programmed cell death-1) and CTLA-4 (cytotoxic T-lymphocyte antigen-4) have revolutionized cancer immunotherapy, providing durable responses in various cancers…
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by harnessing the immune system to target tumors, leading to durable responses in various malignancies. However, the efficacy of ICIs varies…
approach for treating various malignancies. Among the diverse strategies within this field, targeting immune checkpoints has gained significant attention due to its ability to unleash the body's immune system…
realm of cancer treatment, Immune Checkpoint Inhibitors (ICIs) have emerged as a groundbreaking therapeutic approach, marking a significant paradigm shift in cancer immunology. These inhibitors target key regulatory…
immune checkpoint inhibitors (ICIs) expands in clinical practice, our understanding of their potential adverse effects continues to grow. Arising substantiation indicates a connection between ICI remedy and an increased…
immune checkpoint inhibitors (ICIs) expands in clinical practice, our understanding of their potential adverse effects continues to grow. Arising substantiation indicates a connection between ICI remedy and an increased…
Background: Immune checkpoint inhibitors have become part of the standard of care for many forms of solid tumors. Most immune checkpoint inhibitors target the PD (Programmed Cell Death
review examines the present and expanding amount of evidence on the use of immune checkpoint inhibitors in patients with advanced HCC who are awaiting liver transplantation, as well as many ... much greater than single…
cancers. Our study reveals a new gene survival prognostic model from recent immune checkpoint inhibitor (ICIs) databases for glioma cancer. Methods: The Cancer Genome Atlas TCGA transcriptomic analysis and matching…
guidelines for the development of the government units at the Thai cross-border trade checkpoint between Thailand and Malaysia. From the study found that Thai’s government units ... cross-border trade checkpoint have…
Since only a few cases of ovarian cancer could be treated effectively with immune checkpoint inhibitor monotherapy, to improve the prognosis of ovarian cancer, multi-drug therapy including immune checkpoint
patient to patient basis. S-TIR??? vaccines in contrast to the current checkpoint inhibitors do not induce autoimmune disease and are tumour specific. When I designed the vaccines ... when I present this data. I think…
TILs and tumor cells in TNBC and help develop biomarkers to identify responders to checkpoint inhibitors. In this review, we discuss the immunogenic nature of TNBC, the clinical relevance ... TILs and PD-L1 expression…
patients. Herein, we will make a mini review of phenotype-immune checkpoints expression and function of CD8+ T cells in AML based on our data and other groups, and this ... might indicate the application of immune…
dependent (TD) or a Tindependent (TI) antigen immunization with concomitant administration of either checkpoint inhibitors such as antibodies to CTLA-4 or PD-L1 or an antibody to CD40 that ... adjuvant properties…
mechanisms of immune escape employed by tumour cells and the ability to regulate immune checkpoints with immunomodulatory monoclonal antibodies will provide very promising clinical results in different tumour types…
using the participatory ergonomics process that entailed the use of an actionchecklist and ergonomic checkpoints, as well as the review of organizational documents. Eighty seven percent of these study participants…
frequently deploys several immune escape strategies, a problem for the development of checkpoint blockade immunotherapies in these diseases. In particular, there are currently no means to identify those ... DLBCL…
Predictive and prognostic biomarkers are vital for immune checkpoint blockade in solid tumors. Established markers include PD-L1 expression, \textit{Tumor Mutational Burden} (TMB), and Microsatellite Instability (MSI)…
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by unleashing the immune system to target and destroy tumor cells. Despite their significant success in cancers such as melanoma, non-small
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.